Literature DB >> 14726662

Development and cancer: lessons learned in the pancreas.

Patrick W Heiser1, Matthias Hebrok.   

Abstract

Cancer progression and organ development are similar phenomena. Both involve rapid bursts of proliferation, angiogenesis, tissue remodeling, and cell migration. Therefore, it is not surprising that both processes utilize similar signaling machinery. In fact, many recent studies have suggested that cancer is a disease triggered by the erroneous re-activation of signaling pathways that are typically downregulated after the completion of embryonic development. This link between embryonic development and cancer is particularly exciting because it suggests that we might be able to exploit the knowledge gained in studies of Developmental Biology to obtain novel insights into tumor biology. Our evolving understanding of pancreatic adenocarcinoma is an excellent example of this relationship between development and cancer. Here we discuss recent studies have indicated important roles for two major developmental signaling pathways in pancreatic cancer: Notch and Hedgehog (Hh).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726662

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  Genetics and pathology of pancreatic cancer.

Authors:  Jordan M Winter; Anirban Maitra; Charles J Yeo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 2.  Optimum chemotherapy in the management of metastatic pancreatic cancer.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Fadi El Karak; Colette Hanna; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis.

Authors:  Huankai Hu; Lan Zhou; Amad Awadallah; Wei Xin
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-05

4.  Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors.

Authors:  Markus Krausch; Feride Kroepil; Nadja Lehwald; Anja Lachenmayer; Matthias Schott; Martin Anlauf; Kenko Cupisti; Wolfram Trudo Knoefel; Andreas Raffel
Journal:  Endocrine       Date:  2012-12-07       Impact factor: 3.633

5.  Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim.

Authors:  J Konishi; F Yi; X Chen; H Vo; D P Carbone; T P Dang
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

6.  Retinoid signaling in pancreatic cancer, injury and regeneration.

Authors:  Emily K Colvin; Johana M Susanto; James G Kench; Vivienna N Ong; Amanda Mawson; Mark Pinese; David K Chang; Ilse Rooman; Sandra A O'Toole; Davendra Segara; Elizabeth A Musgrove; Robert L Sutherland; Minoti V Apte; Christopher J Scarlett; Andrew V Biankin
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

7.  The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells.

Authors:  Yong-Chao Ma; Chong Shi; Yao-Nan Zhang; Lan-Ge Wang; Hao Liu; Hong-Ti Jia; Yu-Xiang Zhang; Fazlul H Sarkar; Ze-Sheng Wang
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  Autocrine Sonic hedgehog attenuates inflammation in cerulein-induced acute pancreatitis in mice via upregulation of IL-10.

Authors:  Xiangyu Zhou; Zhiqiang Liu; Feng Jang; Chuannan Xiang; Yuan Li; Yanzheng He
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

9.  Role of erlotinib in the management of pancreatic cancer.

Authors:  Naureen Starling; John Neoptolemos; David Cunningham
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

Review 10.  Risk factors and therapeutic targets in pancreatic cancer.

Authors:  Sonja Maria Wörmann; Hana Algül
Journal:  Front Oncol       Date:  2013-11-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.